1. 248 Sustained improvements in disease activity for up to two-years with ixekizumab in patients with active psoriatic arthritis who were either biologic-naïve or with previous inadequate response to tumour necrosis factor inhibitor therapy. (12th April 2019) Authors: Jadon, Deepak R; Nassab, Mani Haschemi; Beneden, Katrien Van; Pum, Georg; Bradley, Andrew J Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 251 Rapid and sustained improvements in patient-reported outcomes with ixekizumab in biologic-naïve and TNF-inadequate responder patients with psoriatic arthritis. (12th April 2019) Authors: Tahir, Hasan; Nassab, Mani Haschemi; Bradley, Andrew; Pum, Georg; Beneden, Katrien Van Journal: Rheumatology Issue: Volume 58(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. No association between the ALDH2 promoter polymorphism rs886205, alcohol dependence, and risky alcohol consumption in a German population. (February 2015) Authors: Nassab, Mani Haschemi; Rhein, Mathias; Heese, Peter; Glahn, Alexander; Frieling, Helge; Linnebank, Michael; Bleich, Stefan; Kornhuber, Johannes; Heberlein, Annemarie; Grallert, Harald; Peters, Annette; Rawal, Rajesh; Strauch, Konstantin; Hillemacher, Thomas Journal: Psychiatric genetics Issue: Volume 25:Number 1(2015:Feb.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗